We believe that this study holds significance because, until now, risk models have been inconsistent in their performance and primarily concentrate on factors linked to HR-positive breast cancer instead of those linked to other less common breast cancer subtypes (HER2-positive cancer and TNBC). This evidence concerns the gene ERBB2 and breast cancer.